Long‐Term Prognostic and Hemodynamic Outcomes of Intensive Immunosuppressive Therapy in Patients With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease
International Journal of Rheumatic Diseases · 2025
DOI: 10.1111/1756-185x.70431 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Kaito Yamada und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Immunosuppressive Agents, Connective Tissue Diseases, Pulmonary Arterial Hypertension, Arterial Pressure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Intensive immunosuppressive therapy (IIT) is recommended for PAH associated with connective tissue disease (CTD‐PAH). However, the long‐term effects of IIT on pulmonary hemodynamics in this population remain unexplored. Additionally, its effectiveness in patients with systemic sclerosis (SSc)‐associated PAH (SSc‐PAH) is poorly understood. Methods and Results This retrospective analysis included 69 consecutive patients with CTD‐PAH treated at our institution (men/women: 9/60, mean age 55.3 ± 14.0 years). Patients were divided into two groups, wherein 41 patients received IIT (IIT group) and 28 did not (non‐IIT group). Both groups received conventional vasodilator therapy. The prognosis and pulmonary hemodynamics were evaluated in all patients. The IIT group exhibited significantly lower rates of PAH‐related mortality ( p < 0.001) compared with the non‐IIT group. The mean PAP (mPAP) improved significantly in the IIT group during the follow‐up (baseline: 38.7 ± 12.2 mmHg; 1 year: 27.0 ± 8.2 mmHg; 5 years: 26.8 ± 7.3 mmHg, p < 0.05), while it remained unchanged in the non‐IIT group. None of the patients with CTD‐PAH required IIT retreatment. Among the 27 patients with SSc‐PAH, the IIT group ( n = 9) showed a significantly greater improvement in mPAP compared with the non‐IIT group ( n = 18) (ΔmPAP at 1 year: −13.4 ± 6.5 mmHg in IIT group vs. −3.0 ± 6.2 mmHg in non‐IIT group, p < 0.001).
Conclusions
This study's findings suggest that IIT may lead to sustained improvements in pulmonary hemodynamics and better long‐term outcomes in patients with CTD‐PAH, including potential benefits in those with SSc‐PAH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
- Teikyo University Graduate School of Public Health, Tokyo, Japan.
- Department of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.
ORCID-Profile: Kaito Yamada
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Yamada, K., Yaoita, N., Satoh, T., Yamamoto, S., Yamada, Y., Chiba, N., Komaru, K., Sato, H., Kikuchi, N., Suzuki, H., Nochioka, K., Tatebe, S., Miyata, S., Ishii, T., & Yasuda, S. (2025). Long‐Term Prognostic and Hemodynamic Outcomes of Intensive Immunosuppressive Therapy in Patients With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70431
Vancouver
Yamada K, Yaoita N, Satoh T, Yamamoto S, Yamada Y, Chiba N, et al. Long‐Term Prognostic and Hemodynamic Outcomes of Intensive Immunosuppressive Therapy in Patients With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70431
BibTeX
@article{Yamada2025,
author = {Yamada, Kaito and Yaoita, Nobuhiro and Satoh, Taijyu and Yamamoto, Saori and Yamada, Yusuke and Chiba, Naoki and Komaru, Kohei and Sato, Haruka and Kikuchi, Nobuhiro and Suzuki, Hideaki and Nochioka, Kotaro and Tatebe, Shunsuke and Miyata, Satoshi and Ishii, Tomonori and Yasuda, Satoshi},
title = {Long‐Term Prognostic and Hemodynamic Outcomes of Intensive Immunosuppressive Therapy in Patients With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease},
journal = {International Journal of Rheumatic Diseases},
year = {2025},
doi = {10.1111/1756-185x.70431}
}
EUVIMED